Opportunities Begin at BioFinance 2011

TORONTO, May 26, 2011 /CNW/ -  Executives from more than 60 Canadian life sciences companies will gather in Toronto next week at BioFinance 2011 to celebrate the industry successes of the previous year and discuss the challenges and opportunities looking forward.

BioFinance 2011 will be held on May 31 and June 1, 2011, at the St. Andrew's Club & Conference Centre and will showcase presentations of the product and investment opportunities of these companies. Fourteen panels comprised of industry experts will explore financing and management issues specific to the life sciences industry.

"There were many successes in the Canadian biotech industry worth celebrating in 2011," said Mr. Michael Stinson, Executive Director of BioFinance Canada. "On the product side, for example, Theratechnologies Inc. completed the lengthy and demanding process for the approval of their novel drug. This was complemented by other companies obtaining approval of specialty pharmaceutical products, medical devices and diagnostic products."

"Also encouraging is that funding of public development stage healthcare companies has shown recent momentum," continued Mr. Stinson. "Equity and convertible debt funding amounted to $259 million in Q4 2010, and seven companies have completed financings of over $10 million so far in 2011." 

Panels at BioFinance 2011 will discuss the numerous sources that Canadian companies have successfully tapped to fund their product development and commercialization efforts. Canadian institutional and venture capital fund managers will provide their perspective on the competition for small cap funding in Canada. The U.S. investment community has been a source of funding for over two decades and will be represented by investment bankers and venture capital fund managers. Partnerships with large biotechnology and pharmaceutical companies will continue as a major source of funding for the smaller companies. 

"Success for the industry in 2011 and subsequent years will be defined by clinical, regulatory and financing achievements, and by share price performance of the companies," said Dr. Wayne Schnarr, Healthcare Consultant for TMX Equicom. "If the industry is able to repeat the clinical and regulatory success rate of 2010, it is expected that financing and share price performance will follow." 

About BioFinance:  

BioFinance is the leading investor conference in Canada for the life sciences industry. The two day event brings together key industry players and companies interested in investment opportunities and issues affecting the life sciences sector. Presenting companies span a range of industries including: biologics, medical devices, drug delivery, vaccines, diagnostics, ag-biotech, and research services.  For more information or to register for BioFinance 2011, please visit www.biofinance.ca

SOURCE BioFinance Canada

For further information:

Michael Stinson
Executive Director
BioFinance Canada

Organization Profile

BioFinance Canada

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890